Education and Training
CHARM seeks to educate and train minority students and fellows.
Salary support is provided to the retained junior faculty, Dr. Oneal, Dr. Nouraie and Dr. Washington. Training has included attendance at the ASH meeting, seminars, discussions of grant progress and problems, program development. We also discussed future training opportunities with faculties who are interested to participate in CHaRM and to apply for pilot projects.
A medical fellow will collaborate with Dr. Oneal and Dr. Nekhai to analyze the prevalence of pulmonary hypertension in patients with SCD.
Two postdoctoral fellows, Dr. Namita Kumari and Dr. Zebalda Bamji were supervised by Dr. Nekhai and Dr. Washington and supported by ChaRM funds.
PhD students training
One student from The Chicago School of Professional Psychology will use data generated under CHaRM for her PhD thesis entitled “Assessing the Relationship of Mood, Anxiety and Alcohol Use Disorders on Hospital Utilization and Mortality in Adult Patients with Sickle Cell disease “under the supervision of Dr. Nouraie. A minority PhD student from the Department of Human Genetics is studying proteomics of proteins excreted in the urine in patients with sickle cell disease, possible biomarkers and etiologic indictaors in renal disease, under the supervision of Dr. Nekhai. We plan to recruit two more Master’s and PhD students from all Basic Science Departments to participate in CHaRM research-intensive studies.
We are developing an administrative component to interact seamlessly with the Graduate School and College of Medicine. MD/PhD students, who are residents in the Medical School, are separate from the Graduate School. We are designing a framework for mentorship, curriculum, and transitioning for MD/PhD students. We are profiling CHaRM investigators and establishing the qualifications for CHaRM investigators who can serve as clinical and basic science mentors. CHaRM is seeking a partnership with the MD/PhD program to participate in medical years 1 and 2 of the MD/PhD seminar series for students to generate interest and recruit for CHaRM research. CHaRM Bridge is establishing the administrative infrastructure to access and integrate Howard University enterprises [i.e. Clinical Translational Science Award (CTSA), Research Centers in Minority Institutions (RCMI), and the National Human Genome Research Center, Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS), etc.] into the training modality for the Bridge programs. The College of Medicine has accepted one applicant with interest in the MD/PhD program; we will participate in the MD/PhD program application process conducted by the MD/PhD program committee. We will offer students the opportunity to conduct exploratory and their thesis research within the CHaRM program.